Figure 1
From: Identification of a CD133−CD55− population functions as a fetal common skeletal progenitor
Expression of CD133 and CD55 in fetal skeletal progenitor.
(A) Representative FACS profiles of E15.5 fetal skeletal cells. They were separated based on CD105 and CD90.1 expression into fetal osteochondral progenitors (CD105+CD90.1−) and osteoprogenitors (CD105+CD90.1+). (B) The expression of CD133 and CD55 in CD105+CD90.1− and CD105+CD90.1+ populations determined by FACS analysis. (C) The gene expression of CD133 and CD55 in CD105+CD90.1− and CD105+CD90.1+ populations. (D,H) Representative FACS profiles of CD133 and CD55 in CD105+CD90.1− (D) and CD105+CD90.1+ (H) populations. (E,I) Distribution of CD133−CD55−, CD133+CD55− and CD133+CD55+ subpopulations in CD105+CD90.1− (E) and CD105+CD90.1+ (I) populations. (F,J) Representative FACS analysis of 6C3 expression in CD105+CD90.1− (F) and CD105+CD90.1+ (J) derived CD133−CD55−, CD133+CD55− and CD133+CD55+ subpopulations. (G,K) Distribution of 6C3 positive cells in CD105+CD90.1− (G) and CD105+CD90.1+ (K) derived CD133−CD55−, CD133+CD55− and CD133+CD55+ subpopulations. (n = 3 for each group. *p < 0.05, **P < 0.010).
